IP Library Granted Patent US 12,349,913
Granted Patent B2
US 12,349,913 · App. 18/671,186 · Granted Jul 8, 2025

Lymphangiogenesis inducing device

Inventor: Manami Kawasaki (Kanagawa, JP)
Assignee: TERUMO KABUSHIKI KAISHA
A61B17/11A61B2017/00247A61B2017/1107A61B17/34A61B17/3417A61B17/3478
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,349,913
App. No.
18/671,186
Granted
Jul 8, 2025
Kind
B2
Abstract

A method of forming a wound for inducing lymphangiogenesis includes: providing a lymphangiogenesis inducing device that includes: a puncture member including a distal end portion configured to puncture living tissue, and a through hole penetrating the puncture member along a central axis and extending from the distal end portion toward a proximal end, and a rod-shaped body inserted into the through hole and configured to be moved so as to protrude from the distal end portion, where the rod-shaped body includes a shaft portion, and a wound imparting structure; puncturing the living tissue with the lymphangiogenesis inducing device while the rod-shaped body is located in the through hole; passing the lymphangiogenesis inducing device through a regeneration route; pulling back the puncture member while the rod-shaped body is left in the living tissue; and pulling back the rod-shaped body.

Claims (25)

1. A method of forming a wound for inducing lymphangiogenesis, the method comprising:

providing a lymphangiogenesis inducing device, which comprises:

a puncture member comprising a distal end portion configured to puncture living tissue, and a through hole penetrating the puncture member along a central axis and extending from the distal end portion toward a proximal end, and

a rod-shaped body inserted into the through hole and configured to be moved so as to protrude from the distal end portion, wherein:

the rod-shaped body comprises a shaft portion, and a wound imparting structure comprising at least one protrusion located on the shaft portion and configured to impart a wound to the living tissue,

identifying a blocked lymphatic vessel;

identifying a regeneration route connecting the blocked lymphatic vessel and an adjacent lymphatic vessel;

puncturing the living tissue with the lymphangiogenesis inducing device while the rod-shaped body is located in the through hole;

passing the lymphangiogenesis inducing device through the regeneration route;

pulling back the puncture member along the regeneration route while the rod-shaped body is left in the living tissue; and

pulling back the rod-shaped body along the regeneration route such that the at least one protrusion forms a wound in the living tissue along the regeneration route.

2. The method according to claim 1 , wherein:

the at least one protrusion comprises a plurality of protrusions protruding outward from the shaft portion.

3. The method according to claim 2 , wherein:

the plurality of protrusions comprises protrusions located at different axial positions and different circumferential positions of the shaft portion.

4. The method according to claim 2 , wherein:

the protrusions have the same protruding height from the shaft portion in a state in which the protrusions are located in the through hole and in a state in which the protrusions are located outside the through hole.

5. The method according to claim 2 , wherein:

the protrusions have a protruding height from the shaft portion that increases when the protrusions transition from a state in which the protrusions are located in the through hole to a state in which the protrusions are located outside the through hole.

6. The method according to claim 5 , wherein:

the protrusions are folded inward when in the state in which the protrusions are located in the through hole, and open outward and protrude when in the state in which the protrusions are outside the through hole.

7. The method according to claim 1 , wherein:

the protrusion is a spiral protrusion.

8. The method according to claim 1 , wherein:

the wound imparting structure has a configuration in which protrusion of the wound imparting structure from the distal end portion and retraction of the wound imparting structure into the through hole are repeatable.

Priority Claims (1)
JP 2020-202523 · Dec 7, 2020 · national
Continuity (2)
Division 17541695 · Dec 3, 2021
Related Publication 20240307060A1 · Sep 19, 2024
References Cited (22)
US 3716058A · Tanner · 1973 [cited by applicant]
US 4874375A · Ellison · 1989 [cited by examiner]
US 5018530A · Rank et al. · 1991 [cited by applicant]
US 5342376A · Ruff · 1994 [cited by applicant]
US 5980548A · Evans et al. · 1999 [cited by applicant]
US 7473232B2 · Teague · 2009 [cited by examiner]
US 10786264B2 · Chegini et al. · 2020 [cited by applicant]
US 20020138098A1 · Black · 2002 [cited by examiner]
US 20050256426A1 · Brugge · 2005 [cited by applicant]
US 20070213634A1 · Teague · 2007 [cited by applicant]
US 20080035160A1 · Woodson et al. · 2008 [cited by applicant]
US 20080066765A1 · Paraschac et al. · 2008 [cited by applicant]
US 20080215072A1 · Kelly · 2008 [cited by applicant]
US 20100305566A1 · Rosenblatt · 2010 [cited by examiner]
US 20140171946A1 · Benson et al. · 2014 [cited by applicant]
US 20160278770A1 · Rustamova · 2016 [cited by applicant]
KR 20140049848A · 2014 [cited by applicant]
WO WO2020162368A1 · 2020 [cited by applicant]
WO WO2020162369A1 · 2020 [cited by applicant]
WO WO2020189157A1 · 2020 [cited by applicant]
Suehiro et al., “Regular Compression Therapy May Not Be Necessary for Lymphedema in Arms without a Subcutaneous Echo-Free Space,” Compression therapy for arm lymphedema without an echo-free space, vol. 62, Jan. 2020, pp… [cited by applicant]
Office Action issued in Japanese Appl. No. 2020-202523 on Jun. 18, 2024. [cited by applicant]